Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Antibody Injections Could Be Stepping Stone to HIV Vaccine

May 17, 2016 9:39 am | by Ivy Shih, The Conversation | News | Comments

Imagine a seasonal jab of antibodies that could neutralize the HIV virus.

TOPICS:

Improving Natural Killer Cancer Therapy

May 17, 2016 7:30 am | by Vanderbilt University Medical Center | News | Comments

Researchers have discovered a potential way to "tune up" the immune system's ability to kill cancer cells.

TOPICS:

HIV Vaccine Design Should Adapt as HIV Virus Mutates

May 17, 2016 7:15 am | by University of Alabama at Birmingham | News | Comments

This process of viral adaptation is constantly occurring, and some adaptations persist even after sequential transmissions to new individuals.

TOPICS:
Advertisement

Scientists Identify Potential Marker of EoE Disease Activity

May 16, 2016 3:00 pm | by Cincinnati Children's Hospital Medical Center | News | Comments

Researchers said that measuring EoP blood levels to monitor disease activity has the potential to reduce discomfort, costs and side effects for patients.

TOPICS:

New Way to Predict COPD Progression

May 16, 2016 2:00 pm | by American Thoracic Society | News | Comments

The amount of NET complexes in the lungs of patients in the study was directly related to the severity of their COPD and the risk of exacerbations.

TOPICS:

J&J CEO: Best of Times, Worst of Times in Healthcare

May 16, 2016 10:16 am | by Ryan Bushey, Digital Editor | Articles | Comments

Alex Gorsky discussed everything from developing new drugs to establishing an appropriate pricing system for these medications.

TOPICS:

IBM Macromolecule Kills Ebola, Herpes, Dengue, Influenza in Tests

May 16, 2016 10:14 am | by Seth Augenstein, Digital Reporter | News | Comments

Computing giant IBM has unveiled a new macromolecule-like “molecular Velcro” to kill viruses like Ebola, herpes, dengue and influenza, according to the company.

TOPICS:

Pfizer Buying Anacor Pharmaceuticals in $5.2B Deal

May 16, 2016 8:19 am | by The Associated Press | News | Comments

Anacor's stock soared more than 53 percent in Monday premarket trading.

TOPICS:
Advertisement

Mylan Strikes $1B Deal for Dermatology Drugs

May 16, 2016 8:05 am | by Ryan Bushey, Digital Editor | Articles | Comments

The acquisition is expected to close by the end of the third quarter.

TOPICS:

Patients with Celiac Disease Should Receive Pneumonia Vaccine

May 16, 2016 8:05 am | by Wiley | News | Comments

Researchers have found that patients with celiac disease are at high risk of acquiring pneumonia if they haven't received the pneumococcal vaccine.

TOPICS:

Vermont to Require Drug Makes to Explain Price Increases

May 16, 2016 8:04 am | by Dave Gram, Associated Press | News | Comments

Vermont is poised to become the first state requiring drug companies to explain their price increases, and Bob and Deborah Messing think that's a good idea.

TOPICS:

Another Reason for Wine Lovers to Toast Resveratrol

May 16, 2016 8:04 am | by Frontiers | News | Comments

Red wine lovers have a new reason to celebrate. 

TOPICS:

Omega-3 Lowers Childhood Aggression in Short-Term

May 16, 2016 8:04 am | by University of Pennsylvania | News | Comments

The Philadelphia randomized control study placed 290 11- and 12-year-olds with a history of violence into four groups.

TOPICS:

Pfizer Says It's Blocking Use of Drugs for Lethal Injections

May 16, 2016 7:00 am | by Andrew Welsh-Huggins, Associated Press | News | Comments

The company's announcement has limited immediate impact.

TOPICS:

NIH-Led Team Discovers New HIV Vaccine Target

May 16, 2016 6:30 am | by National Institute of Health | News | Comments

A team led by NIH scientists have reported a research trifecta. 

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading